Eyeworld

Reporting from the XXXIII Congress of the ESCRS, September 5–9, Barcelona EW MEETING REPORTER 144 October 2015 office with a white cataract and total LSCD? This would require treatment for the already existing cataract. He suggested enhancing visualization by methylcellulose, trypan blue, or a lighting approach. Surgeons can also attempt a lamellar graft, he said. Usually the opacity is superficial and can be removed with a shallow inci- sion. "Surgery is relatively easy, but what's not easy is the follow-up," he However, this is not a possible option for a patient who has total stem cell disease. In total LSCD, an ex vivo expansion may be per- formed, or the surgeon may want to do a simple limbal epithelial trans- plantation (SLET). This is a simple, one-stage procedure, but currently there is no long-term data for SLET. What happens, Dr. Kruse ques- tioned, if a patient comes into your said. You do not cure the underlying disease, so recurrence is quite likely, he said. Lamellar grafts are not a treatment option for the LSCD. Epithelial basement membrane dystrophy Per Fagerholm, MD, Linkoping, Sweden, discussed epithelial base- ment membrane dystrophy (EBMD) in his presentation. EBMD has had many names over time, he said. This is a disease that is seldom inherited. Symptoms of EBMD are changing refraction, reduced visual acuity up to 7 lines, and recurrent erosions in 30% of cases. This is a fairly com- mon problem, Dr. Fagerholm said, as about 6–18% of the population have it. EBMD is associated with a lot of other diseases, particularly dry eyes. Although EBMD may be difficult to diagnose because of its painless and sometimes sudden visual disturbanc- es, there are several therapy options, including lubricants, epithelial debridement and Bowman's layer polishing, diamond burr treatment, and PTK. Lubricants are important because they improve vision in most of these patients, he said. Opening ceremony At the opening ceremony of the XXXIII ESCRS Congress, ESCRS president Roberto Bellucci, MD, Verona, Italy, welcomed attendees to the meeting. This was followed by welcomes from the local hosts, Jose Alfonso, MD, PhD, Madrid, and Jose Güell, MD, PhD, Barcelona. Dr. Bellucci said he is sure that after the meeting all attendees will return home with new information to use in their clinical practices. Ed- ucation and clinical research are the 2 pillars of ESCRS, he said. ESCRS also has an ongoing commitment to training ophthalmologists for the future, and invests significantly in research activities, including the PREMED study on the PREvention of Macular EDema after Cataract Sur- gery, EUREQUO, its Patient-Reported Outcomes Questionnaire, and the FLACS study. There is "an extensive scientific program" scheduled for the 5 days of the congress, he said. Last year, ESCRS featured 7 new sessions ∠ 刀攀愀搀礀 琀漀 甀猀攀 ∠ 一漀 猀瀀氀椀琀琀椀渀最 漀爀 挀甀琀琀椀渀最 ∠ 䄀氀氀漀眀猀 戀攀琀琀攀爀 挀漀猀洀攀琀椀挀 爀攀猀甀氀琀猀 ∠ 䈀攀琀琀攀爀 瀀愀琀椀攀渀琀 挀漀洀昀漀爀琀   一漀眀 爀攀椀洀戀甀爀猀攀搀 愀琀 䄀匀䌀猀 眀椀琀栀 瀀愀猀猀ⴀ琀栀爀漀甀最栀 挀漀搀攀⸀ 眀椀琀栀 瀀愀猀猀ⴀ琀栀爀漀甀最栀 挀漀搀攀⸀ 䌀氀攀愀爀 䌀漀爀渀攀愀 䜀爀愀昀琀 昀爀漀洀 一攀眀 圀漀爀氀搀 䴀攀搀椀挀愀氀Ⰰ 椀渀挀⸀ 眀眀眀⸀一攀眀圀漀爀氀搀䴀攀搀椀挀愀氀⸀挀漀洀 㠀　　⸀㠀㌀㈀⸀㔀㌀㈀㜀 ㄀　㜀㘀㌀ 䔀搀椀猀漀渀 䌀漀甀爀琀Ⰰ 刀愀渀挀栀漀 䌀甀挀愀洀漀渀最愀Ⰰ 䌀䄀 㤀㄀㜀㌀　 一攀眀 圀漀爀氀搀 䴀攀搀椀挀愀氀Ⰰ 䤀渀挀⸀

• Cover